In addition to its pivotal role in the coagulation cascade, thrombin i
s mitogenic for fibroblasts and endothelial cells, and activates a num
ber of inflammatory cells including monocytes and T-lymphocytes. To de
termine if other immune functions are modulated by thrombin and if thi
s modulation is direct or indirect, we investigated whether highly pur
ified human alpha-thrombin affects natural killer (NR) and lymphokine-
activated killer (LAI) cell-mediated cytotoxicity. Thrombin enhanced N
R cell-mediated cytotoxicity by more than 60% and enhanced IL-2 produc
tion and NK 3.3 cell responsiveness to IL-2. Unexpectedly, thrombin an
d the receptor activating ''tethered ligand'' domain of the thrombin r
eceptor (TRP-7:SFLLRNP) inhibited LAK cell-mediated cytotoxicity by 50
%. DIP-thrombin (a proteolytically inactive form of alpha-thrombin) ha
d no inhibitory activity, suggesting that proteolytic activation of th
rombin receptor is requisite for inhibition. These results indicate th
at cell-mediated cytotoxicity may be enhanced by thrombin through a me
chanism involving stimulation of cytokine production and NK cell respo
nsiveness, but that activation of thrombin receptor may also inhibit c
ytotoxic effects of LAK: cells. The role of this dual regulation in pr
ocesses of cell surveillance, wound healing, and inflammation remains
to be determined. (C) 1996 Academic Press, Inc.